Genetically engineered organs for early reporting of transplant rejection
Molecular Therapy · 2026
DOI: 10.1016/j.ymthe.2025.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Irina Filz von Reiterdank und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Engineering for Medicine and Surgery, Department of Surgery, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, MA 0211…. Hauptthemen laut MEDLINE: Graft Rejection, Genetic Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, Shriners Children's Boston, National Institutes of Health.
Abstract (Originalsprache)
Diagnosis of organ transplant rejection remains limited by the low sensitivity and specificity of blood tests and the invasive nature of biopsies. This study introduces an innovative approach for detecting rejection through the genetic modification of transplant organs. Using lentiviral vectors, we delivered immunoresponsive transgenes to vascularized composite allografts during ex vivo normothermic machine perfusion. This enabled in situ detection of rejection via secretion of the reporter protein Gaussia luciferase (GLuc) into the circulation. We demonstrated long-term stability of constitutive transgene expression beyond 500 days, the human equivalent of about 50 years. When GLuc expression was driven by a synthetic nuclear factor kappa B promoter, these inflammation-responsive organs enabled the non-invasive monitoring of rejection that preceded histological changes by 6 days. Our findings demonstrate the potential of combining gene therapy and machine perfusion to enhance the diagnostic capabilities of transplantable organs, offering a promising avenue for improving long-term graft survival and patient outcomes in transplant medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Engineering for Medicine and Surgery, Department of Surgery, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, MA 02114, USA; Shriners Children's Boston, Boston, MA 02114, USA; Department…
- Center for Engineering for Medicine and Surgery, Department of Surgery, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, MA 02114, USA; Shriners Children's Boston, Boston, MA 02114, USA.
- Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Department of Plastic, Reconstructive and Hand Surgery, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.
- Department of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: biju.parekkadan@rutgers.edu.
- Center for Engineering for Medicine and Surgery, Department of Surgery, Massachusetts General Hospital (MGH), Harvard Medical School, Boston, MA 02114, USA; Shriners Children's Boston, Boston, MA 02114, USA. Electronic…
Förderung
- NIBIB NIH HHS
- Shriners Children's Boston
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Filz von Reiterdank, I., Bento, R., Dinicu, A. T., Taveras, C., Hassan, M., Mojoudi, M., Chen, H., Ellis, B. W., Wojtkiewicz, G., Weissleder, R., Uygun, B. E., Cetrulo, C. L., Coert, J. H., Mink van der Molen, A. B., Parekkadan, B., & Uygun, K. (2026). Genetically engineered organs for early reporting of transplant rejection. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.10.024
Vancouver
Filz von Reiterdank I, Bento R, Dinicu AT, Taveras C, Hassan M, Mojoudi M, et al. Genetically engineered organs for early reporting of transplant rejection. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2025.10.024
BibTeX
@article{FilzvonReiterdank2026,
author = {Filz von Reiterdank, Irina and Bento, Raphaela and Dinicu, Antonia T and Taveras, Christopher and Hassan, Madeeha and Mojoudi, Mohammadreza and Chen, Huyun and Ellis, Bradley W and Wojtkiewicz, Gregory and Weissleder, Ralph and Uygun, Basak E and Cetrulo, Curtis L and Coert, J H and Mink van der Molen, Aebele B and Parekkadan, Biju and Uygun, Korkut},
title = {Genetically engineered organs for early reporting of transplant rejection},
journal = {Molecular Therapy},
year = {2026},
doi = {10.1016/j.ymthe.2025.10.024}
}
EUVIMED